- Definitive Healthcare prices IPO at $420M, eyes Nasdaq
- Scoop: Bob Nelsen is building a Really Big Neuroscience Company
- Phio Pharmaceuticals Presents Data at ESMO 2021 Demonstrating Persistent Anti-Tumor Immunity with INTASYL Dual-Targeting PD-1 and BRD4
- Leap Therapeutics Presents Updated Positive Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ESMO Congress
- Mark Sutton named North American CEO of the Year Winner
- Flagship Pioneering Announces Appointment of Kathy Biberstein as General Counsel
- AIDS activists to protest Moderna for ‘pandemic profiteering’
- Here are the highest-paid Mass. hospital executives for 2019
- QurAlis Announces Development Candidate for ALS Targeting STATHMIN-2
- EyePoint Pharmaceuticals to Present Data at the American Academy of Ophthalmology (AAO) 2021 Annual Meeting
Copyright © 2021 Biotech Networks, LLC
